Log in Book a Demo

US Pharma & Biotech Cardiology - PPC Market Share Analysis July 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Cardiology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Cardiology – US

Google AI Overview visibility for Pharma & Biotech Cardiology US

See how often AIOs appear and how search intent is distributed across buying signals.

See more data

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency Percentage
Frequency 78.1055192337
21.8944807663
78%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency Percentage
Frequency 19
81
19%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent Distribution
Investigational 2%
Transactional 8%
Navigational 2%
Seasonal 0%
Local 0%
Problem Solving 23%

Copyright © Adthena. All rights reserved.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Cardiology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Share of Clicks - Last month
Domain Share of clicks
repatha.com 53.94
repathahcp.com 25.24
goodrx.com 3.08
telyrx.com 3
leqviohcp.com 2.16
bmscustomerconnect.com 1.71
vyndamax.com 1.59
lipitor.com 1.24
vyndamax.pfizerpro.com 0.94
leqvio.com 0.8
others 6.3
  • repatha.com - 53.94%
  • repathahcp.com - 25.24%
  • goodrx.com - 3.08%
  • telyrx.com - 3%
  • leqviohcp.com - 2.16%
  • bmscustomerconnect.com - 1.71%
  • vyndamax.com - 1.59%
  • lipitor.com - 1.24%
  • vyndamax.pfizerpro.com - 0.94%
  • leqvio.com - 0.8%
  • others - 6.3%

Copyright © Adthena. All rights reserved.

In the PPC landscape, repatha.com dominates with 53.94% click share, followed by repathahcp.com at 25.24%. Others collectively hold 6.30%, while goodrx.com and telyrx.com trail behind.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Cardiology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Share of Spend - Last Month
Date repatha.com repathahcp.com vyndamax.com leqviohcp.com vyndamax.pfizerpro.com goodrx.com telyrx.com amvuttra.com leqvio.com lipitor.com
2026/07/01 47.93% 33.22% 2.89% 3.18% 1.41% 0.2% 3.24% 1.13% 0.46% 0.1%
2026/07/02 36.6% 32.84% 2.09% 3.06% 1.05% 5.32% 11.47% 0.75% 0.46% 0.27%
2026/07/03 45.52% 37.16% 2.3% 4% 1.23% 0.83% 0.68% 0.89% 0.35% 0.07%
2026/07/04 50.83% 30.31% 1.39% 5.05% 0.77% 0.5% 2.54% 0.69% 0.31% 0.05%
2026/07/05 51.94% 26.1% 1.36% 4.29% 0.86% 5.39% 2.67% 0.79% 0.65% 0.11%
2026/07/06 43.42% 36.14% 1.49% 4.61% 0.98% 0.64% 6.07% 0.52% 0.27% 0.03%
2026/07/07 40.76% 35.18% 2.06% 4.05% 1.25% 1.61% 6.23% 0.83% 1.32% 0.07%
2026/07/08 44.2% 35.19% 1.47% 3.24% 0.86% 0.62% 9.08% 0.49% 0.41% 0.03%
2026/07/09 48.81% 36.19% 1.9% 3.03% 1.09% 0.62% 2.86% 0.76% 0.33% 0.06%
2026/07/10 49.46% 35.17% 2.4% 2.28% 1.14% 1.35% 0.04% 0.98% 1.97% 0.07%
2026/07/11 49.6% 36.22% 2.21% 2.25% 1.04% 0.93% 0.02% 0.99% 0.96% 0.04%
2026/07/12 50.28% 31.37% 1.55% 2.92% 0.91% 1.36% 1.6% 0.98% 0.97% 0.04%
2026/07/13 44.57% 32.92% 2.53% 2.51% 1.79% 1.33% 0.63% 1.2% 1.39% 0.26%
2026/07/14 45.38% 37.09% 1.61% 3.21% 1.15% 0.93% 0.01% 0.48% 2.87% 0.05%
2026/07/15 49.47% 37.58% 2.11% 2.11% 1.44% 0.69% 0.55% 0.67% 1.51% 0.05%
2026/07/16 55.01% 32.59% 2.77% 0.64% 1.46% 0.91% 0.02% 1.05% 1.17% 0.1%
2026/07/17 55.23% 26.45% 2.29% 1.39% 1.13% 0.46% 7.79% 1.42% 0.3% 0.08%
2026/07/18 58.25% 28.6% 2.39% 3.14% 0.96% 0.48% 0.02% 0.93% 1.65% 0.05%
2026/07/19 53.96% 25.55% 2.2% 2.66% 1.35% 6.15% 0.03% 1.11% 1.16% 0.14%
2026/07/20 58.49% 26.92% 3.03% 1.61% 1.97% 0.72% 0.02% 1.25% 0.19% 0.09%
2026/07/21 45.12% 36.88% 1.6% 3.36% 1.14% 0.92% 0.01% 0.48% 2.86% 0.05%
2026/07/22 53.97% 25.16% 1.93% 1.86% 1.38% 2.03% 0.96% 0.76% 1.04% 0.06%
2026/07/23 55.09% 31.58% 2.23% 1.86% 1.26% 0.51% 0.59% 0.94% 0.85% 0.08%
2026/07/24 55.53% 28.64% 1.95% 2.16% 0.93% 1.39% 0.75% 0.73% 0.82% 0.11%
2026/07/25 56.42% 26.51% 1.72% 2.51% 0.98% 0.79% 3.15% 0.76% 0.93% 0.11%
2026/07/26 48.88% 27.93% 2.39% 2.69% 1.58% 0.9% 3.02% 0.83% 0.99% 3.15%
2026/07/27 43.41% 21.24% 2.19% 2.35% 1.25% 0.51% 0.92% 0.84% 1.74% 16.82%
2026/07/28 51.58% 29.13% 2.7% 0.8% 1.59% 0.82% 2.65% 0.96% 1.73% 0.1%
2026/07/29 49.37% 25.39% 2.42% 0.68% 1.14% 6.09% 0.53% 0.68% 1.81% 4.05%
2026/07/30 53.74% 33.04% 1.84% 1.19% 1% 0.68% 1.06% 0.74% 1.33% 0.05%
2026/07/31 57.7% 31% 1.95% 1.48% 0.99% 0.73% 0.59% 0.48% 0.32% 0.03%
  • repatha.com
  • repathahcp.com
  • vyndamax.com
  • leqviohcp.com
  • vyndamax.pfizerpro.com
  • goodrx.com
  • telyrx.com
  • amvuttra.com
  • leqvio.com
  • lipitor.com

Copyright © Adthena. All rights reserved.

In July 2026, repatha.com dominated with a steady rise, peaking at 58.49%. Meanwhile, repathahcp.com fluctuated, ending at 31.0%. Vyndamax.com and leqviohcp.com showed minor variations. Lipitor.com spiked dramatically on July 27, closing at 0.03%.

Market Exposure

Competitor Count for US Pharma & Biotech Cardiology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Competitor Count - Last month
Date Competitor Count
2026/07/01 47
2026/07/02 45
2026/07/03 46
2026/07/04 48
2026/07/05 47
2026/07/06 45
2026/07/07 44
2026/07/08 40
2026/07/09 46
2026/07/10 44
2026/07/11 40
2026/07/12 45
2026/07/13 46
2026/07/14 44
2026/07/15 40
2026/07/16 42
2026/07/17 41
2026/07/18 43
2026/07/19 38
2026/07/20 37
2026/07/21 44
2026/07/22 47
2026/07/23 43
2026/07/24 46
2026/07/25 43
2026/07/26 50
2026/07/27 49
2026/07/28 47
2026/07/29 44
2026/07/30 44
2026/07/31 45

Copyright © Adthena. All rights reserved.

July saw fluctuating advertiser numbers, starting at 47, dipping mid-month to 37, then rebounding to 45 by month’s end.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Cardiology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Market Loss & Market Gains - Last month
Name Market Trend
repatha.com 2.55%
lipitor.com 2.49%
bmscustomerconnect.com 0.41%
goodrx.com 0.37%
familywize.org 0.33%
nexlizethcp.com -0.21%
cedars-sinai.org -0.23%
leqviohcp.com -0.96%
telyrx.com -2.17%
repathahcp.com -3.85%

Copyright © Adthena. All rights reserved.

Repathahcp.com and telyrx.com saw declines, while repatha.com and lipitor.com experienced significant click share growth.

Campaign Efficiency

US Pharma & Biotech Cardiology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date repathahcp.com repatha.com leqviohcp.com amvuttra.com telyrx.com vyndamax.pfizerpro.com tryngolzahcp.com goodrx.com leqvio.com lipitor.com
2026/07/01 42.45% 22.55% 4.42% 2.48% 12.91% 1.39% 0.02% 0.26% 0.55% 0.1%
2026/07/02 36.65% 16.9% 4.49% 1.58% 17.73% 0.94% 0.01% 9.96% 0.27% 0.18%
2026/07/03 49.17% 19.74% 7.14% 2.39% 2.73% 1.47% 0% 1.52% 0.51% 0.07%
2026/07/04 40.93% 25.22% 8.17% 1.76% 6.92% 0.91% 0.02% 1.05% 0.37% 0.06%
2026/07/05 34.37% 20.96% 7.64% 2.06% 9.35% 1.04% 0% 10.68% 1.08% 0.11%
2026/07/06 42.04% 21.48% 7.31% 1.16% 15.2% 1.01% 0.16% 0.97% 0.28% 0.02%
2026/07/07 40.4% 19.59% 6.11% 1.71% 15.09% 1.14% 0.14% 2.25% 1.75% 0.07%
2026/07/08 43.81% 23.32% 5.7% 1.14% 14.9% 0.88% 0% 0.99% 0.56% 0.03%
2026/07/09 45.69% 26.76% 5.04% 1.83% 8.54% 1.21% 0% 0.59% 0.66% 0.08%
2026/07/10 49.23% 21.25% 4.27% 2.62% 0.21% 1.42% 0.01% 2.26% 2.32% 0.09%
2026/07/11 47.03% 25.25% 4.28% 2.52% 0.05% 1.22% 0% 1.71% 1.81% 0.05%
2026/07/12 40.38% 27.31% 5.13% 2.53% 3.11% 0.98% 0% 2.56% 2.03% 0.05%
2026/07/13 41.22% 21.01% 3.43% 2.44% 1.38% 1.71% 4.34% 1.75% 2.23% 0.19%
2026/07/14 47.66% 24.89% 5.25% 1.19% 0.03% 1.21% 2.19% 0.77% 5.01% 0.05%
2026/07/15 53.32% 25.44% 3.14% 2.09% 1.84% 1.72% 1.4% 0.92% 2.81% 0.06%
2026/07/16 48.82% 29.4% 1.47% 2.94% 0.05% 1.85% 0.73% 1.15% 2.31% 0.15%
2026/07/17 35.31% 24.03% 2.6% 3.08% 24% 1.3% 0.08% 0.63% 0.61% 0.11%
2026/07/18 42.8% 33.59% 5.21% 2.76% 0.09% 1.25% 0.09% 0.8% 3.15% 0.06%
2026/07/19 33.88% 21.76% 4.75% 2.83% 0.09% 1.57% 0.18% 12.38% 2.27% 0.12%
2026/07/20 43.65% 30.84% 2.66% 3.68% 0.07% 2.58% 0.13% 0.96% 0.41% 0.13%
2026/07/21 47.66% 24.89% 5.25% 1.19% 0.03% 1.21% 2.19% 0.77% 5.01% 0.05%
2026/07/22 37.94% 27.11% 3.54% 2.07% 2.98% 1.74% 0.84% 3.75% 1.89% 0.09%
2026/07/23 49.32% 25.31% 3.39% 2.48% 1.98% 1.6% 0.49% 0.73% 1.88% 0.12%
2026/07/24 44.98% 25.1% 4.2% 1.95% 2.71% 1.21% 1.15% 2.6% 1.48% 0.18%
2026/07/25 39.03% 26.13% 5.12% 1.92% 10.77% 1.2% 0.33% 0.89% 1.73% 0.11%
2026/07/26 33.52% 21.8% 3.8% 1.77% 8.4% 1.67% 1.34% 0.95% 1.71% 9.17%
2026/07/27 22.42% 16.16% 2.76% 1.49% 2.11% 1.03% 15.65% 0.51% 1.9% 23.11%
2026/07/28 37.56% 27.89% 1.73% 2.09% 7.48% 1.78% 0.6% 0.85% 2.94% 0.11%
2026/07/29 30.13% 23.49% 1.1% 1.61% 0.98% 1.14% 1.12% 12.47% 2.98% 10.07%
2026/07/30 45.7% 31.53% 2.11% 1.85% 2.83% 1.16% 0.72% 0.73% 2.4% 0.05%
2026/07/31 45.2% 33.69% 3.15% 1.49% 1.28% 1.24% 1.2% 1.01% 0.72% 0.01%
  • repathahcp.com
  • repatha.com
  • leqviohcp.com
  • amvuttra.com
  • telyrx.com
  • vyndamax.pfizerpro.com
  • tryngolzahcp.com
  • goodrx.com
  • leqvio.com
  • lipitor.com

Copyright © Adthena. All rights reserved.

In July 2026, repathahcp.com led with fluctuating impressions, peaking mid-month. Repatha.com showed steady growth, while leqviohcp.com and amvuttra.com had minor variations. Telyrx.com and goodrx.com experienced significant spikes. The month concluded with repathahcp.com maintaining dominance.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology - Last month
  1. 1
    LEQVIO® (inclisiran) HCP Site - Injection Treatment Option https://www.leqviohcp.com/efficacy

    Understand How LEQVIO® May Work To Treat Your Patients. Watch A Mechanism Of Action Video.

  2. 2
    Repatha® (evolocumab) - Official Site For Patients https://www.repatha.com/

    Visit the Official Patient Website for Product Information About Repatha. Learn More About Financial Support And Coverage. See Copay Eligibility Information. What Is Repatha®? Side Effects of Repatha®. Is Repatha Right For Me?

  3. 3
    Repatha® (evolocumab) - Dosing & Administration https://www.repathahcp.com/

    Learn More About Repatha by Visiting the Official Product Website for Physicians. Watch Videos & Discover Insights from Healthcare Professionals About the Role of Repatha.

  4. 4
    Understand Rosuvastatin side effects https://www.telyrx.com/

    Learn what rosuvastatin is, how it works, common side effects, and how to get it prescribed and delivered online through TelyRx.com

  5. 5
    HCP Site - FDA-Approved Treatment - NAFCS Scoring Tool

    Use The NAFCS Scoring Tool To Assess Adult Patients Who May Have FCS.

Copyright © Adthena. All rights reserved.

In the competitive landscape of cardiology PPC ads, Leqvio and Repatha dominate with targeted messaging. Leqvio emphasizes treatment efficacy through educational videos, while Repatha focuses on patient support and physician insights. TelyRx highlights rosuvastatin’s side effects, offering online prescriptions.

Frequently Asked Questions

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.